Quality of informed consent in clinical trials (#361)
3:00 PM
RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) + PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy: A subgroup analysis of Western population (#362)
3:00 PM
Analysis of adjuvant chemotherapy in early stage Merkel Cell Carcinoma (#363)
3:00 PM
P16 Prevalence and incidence of recurrence in different subsites of oropharyngeal cancer: Retrospective analysis at single level institution from 2011-2012 (#364)
3:00 PM
Significant relationship between MTHFR C677T polymorphism and gastric cancer in Fars (#365)
3:00 PM
Serum vitamin A, E, C and catalase in active and passive smokers in Nigeria (#366)
3:00 PM
Genetic and epigenetic changes and their effect on prognosis and prediction of colorectal cancer (#367)
3:00 PM
The impact of medical emergency team response on patterns of care at the end-of-life for people with incurable cancer (#368)
3:00 PM
Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (LCCRT) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital (#369)
3:00 PM
Assessment of long course chemoradiotherapy (LCCRT) in regards to completion of chemotherapy. The experience of a tertiary referral hospital (#370)
3:00 PM
Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (LCCRT). An assessment at a tertiary referral hospital (#371)
3:00 PM
Locally advanced and metastatic pancreatic cancer: An assessment of the provision of chemotherapy at a tertiary referral hospital (#372)
3:00 PM
Circulating tumour cells in early stage breast cancer The EMPathy Breast Cancer Network (#373)
3:00 PM
Ipilimumab versus placebo after complete resection of stage III melanoma: efficacy and safety results from the EORTC 18071 phase III trial (#374)
3:00 PM
Safety of combined exemestane and everolimus in postmenopausal hormone receptor positive metastatic breast cancer patients – a retrospective analysis (#375)
3:00 PM
Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases. (#376)
3:00 PM
Comparison and Correlation of Vascular Endothelial Growth Factor (VEGF) Expression in Non Malignant Lesion, Premalignant Lesion and Squamous Cell Carcinoma (SCC) of Oral Cavity (#377)
3:00 PM
Long-term survival of ipilimumab-naïve patients with advanced melanoma (MEL) treated with nivolumab (anti-Programmed Death-1; anti-PD-1; BMS-936558; ONO-4538) in a phase I trial. (#378)
3:00 PM
Safety of treatment of liver carcinoma by percutaneous acetic acid injection: A preliminary report (#379)
3:00 PM
Clinical significance of p53 and 4E molecular marker expression in head and neck squamous cell carcinoma of Northern Territory patients: An Australian retrospective study (#380)
3:00 PM
Basic physical fitness testing protocol: What can it tell us about women touched by breast cancer? (#381)
3:00 PM
Compliance with international guidelines and readability of informed consent forms for cancer clinical trials (#383)
3:00 PM
Administration of chemotherapy in patients on dialysis (#384)
3:00 PM
Improving delivery of ambulatory care for cancer patients: experience of the Rapid Assessment Clinic in a tertiary institution (#385)
3:00 PM
Adjuvant chemotherapy in stage III colon cancer: A regional cancer care centre experience. (#386)
3:00 PM
Integration of scientists and clinical experts in Australia’s first molecular tumour board from the Victorian Comprehensive Cancer Centre (VCCC). (#387)
3:00 PM
An initial analysis of preoperative serum microRNA-21 levels for the detection of ovarian carcinoma in patients with a pelvic mass (#388)
3:00 PM
Ki67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma (#389)
3:00 PM
Plasma miR-320, miR-let-7e and miR-21 as novel potential biomarker for retinoblastoma detection (#390)
3:00 PM
Evaluation of patient characteristics, clinical profile and treatment outcomes in glioblastoma multiforme: An institutional analysis (#391)
3:00 PM
Nutrition screening and association with chemotherapy outcomes in older cancer patients (#392)
3:00 PM
High-Risk Cutaneous Squamous Cell Carcinoma of Head and Neck with Parotid Metastasis: a review of 151 patients Treated at a Tertiary Referral Centre. (#393)
3:00 PM
Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals (#394)
3:00 PM
Intravenous versus oral flouropyramidine: Post gastrectomy chemoradiation (#395)
3:00 PM
Doctor-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors (#396)
3:00 PM
Communication and information processing in patients with primary or metastatic brain malignancy – a survey of practice in two NSW metropolitan radiotherapy centres (#397)
3:00 PM
Cytokine receptor expression in acute myeloid leukemia: High expression of interleukin-2 receptor α-chain predicts a poor prognosis (#398)
3:00 PM
Four year outcomes after regional lymphadenectomy for stage III melanoma. (#399)
3:00 PM
Response to chemotherapy in patients with gestational trophoblastic neoplasia and subsequent fertility (#400)
3:00 PM
Comparison of clinical profile of oral cancers in young and elderly patients - A single institution series from South India (#401)
3:00 PM
Fertility preservation toolkit: implementing & evaluating a resource to assist clinical discussion & decision making regarding fertility in paediatric oncology (#402)
3:00 PM
Melanoma in the elderly, a different spectrum of disease? (#403)
3:00 PM
Operable colorectal liver metastases: An Australian Institution Experience (#404)
3:00 PM
Punching above the weight - high-dose methotrexate chemotherapy in extremes of body size (#405)
3:00 PM
Characteristics and Clinical Outcomes of Invasive Lobular Carcinoma of the Breast (#406)
3:00 PM
Impact of histopathological profile on 1.5-years disease progression of breast cancer patients: evidence from the Philippine DOH-Breast Cancer Medicine Access Program in medical oncology clinics of two tertiary hospitals (#407)
3:00 PM
Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis (#408)
3:00 PM
Gastrectomy for gastric carcinoma: A systematic review of quality of life (#409)
3:00 PM
Trans-arterial Embolisation Therapies for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review (#410)
3:00 PM
Assessment of surgical downstaging in an open-label Phase 2 trial of denosumab in patients with Giant Cell Tumour of Bone (#411)
3:00 PM
Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-Programmed Death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL). (#412)
3:00 PM
Applying social-cognition models to understand women’s hypothetical intentions for Contralateral Prophylactic Mastectomy (#414)
3:00 PM
Single Institution Review of the Tolerability and Efficacy of Post Chemotherapy Abiraterone Acetate in a Regional Cancer Centre. (#415)
3:00 PM
Rapid fluorodeoxyglucose-positron emission tomography (FDG-PET) response to denosumab treatment in patients with giant cell tumour of bone (GCTB): results from two phase 2 trials (#416)
3:00 PM
Haematological Cancer Patients’ Views on Tissue Banking (#417)
3:00 PM
Implementing a protocol for vitamin-D screening and replacement in cancer patients (#420)
3:00 PM
Training benefits of a Learning Management System (LMS) (#421)
3:00 PM
A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy and their female partners (#422)
3:00 PM
Appetite for e-learning - educating clinicians on cancer malnutrition (#423)
3:00 PM
Aflibercept in metastatic colorectal cancer (mCRC): Data from clinical trials, lessons from clinical practice (#424)
3:00 PM
Development and implementation of the “Introduction to Oncology for Physiotherapists” study day (#425)
3:00 PM
Bridging the gap between city and country: A regional interdisciplinary educational workshop and DVD production in head and neck and upper gastrointestinal cancer management (#426)
3:00 PM
An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? (#427)
3:00 PM
Carcinoma tongue a retrospective review of treatment and outcome in 643 patients who had surgery as a primary modality of treatment (#428)
3:00 PM
Risk factors for metachronous colorectal neoplasia: a systematic review and meta-analysis (#429)
3:00 PM
Posttraumatic stress disorder and posttraumatic growth in breast cancer patients - a logical analysis (#430)
3:00 PM
A study on cancer incidence in Nepal from 2003 -2010 (#431)
3:00 PM
The Prevalence of Complementary and Alternative Medicine Use Among Patients With Malignancy at Royal Hobart HospitalLowenthal, R, Verma, N 2013 (#432)
3:00 PM
Commencement of an allied health led, pre-radiation treatment group education session for head and neck cancer patients and carers (#433)
3:00 PM
Learning Management System (LMS), the benefits of reporting (#434)
3:00 PM
Pazopanib toxicity monitoring (#435)
3:00 PM
A different direction for social work in assisting those affected by mesothelioma (#436)
3:00 PM
Prostatectomy Clinic (#437)
3:00 PM
A retrospective study on rural oncology patient pathways (#438)
3:00 PM
The Evolution of a Multidisciplinary Cancer Cachexia Clinic (#439)
3:00 PM
The Northern Health Outpatient Psycho-Oncology Service: Referral patterns and change in psychological distress over time. (#440)
3:00 PM
The highs and lows of the MDT: Experiences of working in a multidisciplinary team from the perspective of the Prostate Cancer Specialist Nurse in Tamworth, NSW. (#441)
3:00 PM
Outreach Clinic vs. Community Outreach: What’s in a name? A service provision review from the Prostate Cancer Specialist Nurse in Tamworth, NSW. (#442)
3:00 PM
A model of youth friendly genetic counselling (#443)
3:00 PM
Bloomhill Cancer Help: A unique community owned and operated cancer support service model. (#444)
3:00 PM
Investigation of the total and Short Form Patient Generated Subjective Global Assessment (Short Form PG-SGA) score as a screening tool in chemotherapy outpatients (#445)
3:00 PM
A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21) (#446)
3:00 PM
The Colon Health And Life-Long Exercise ChaNgE (CHALLENGE) Trial: Participant adherence to fitness assessments (#447)
3:00 PM
The support needs of terminally ill people living alone at home: A narrative review (#448)
3:00 PM
Why do oncology outpatients who report emotional distress decline help? (#449)
3:00 PM
Psychiatry registrars’ views and educational needs regarding the care of patients with life-limiting illnesses (#450)
3:00 PM
Insomnia in cancer (#451)
3:00 PM
Predictors of high levels of distress and unmet needs in carers of High Grade Glioma patients over time (#452)
3:00 PM
Patient, caregiver and healthcare professional’s experiences and perceptions of advance care planning in cancer patients: a systematic review (#453)
3:00 PM
Suitability of Cancer Registries for Recruiting Patients with Low-Incidence Cancers for Supportive Care Studies (#454)
3:00 PM
Supporting someone with cancer: the development and implementation of a carer support program at the Olivia Newton-John Cancer & Wellness Centre (ONJCWC). (#456)
3:00 PM
Havin’ A Yarn: A project to support Aboriginal people affected by cancer (#457)
3:00 PM
The nurses’ role in monitoring patients with advanced melanoma receiving Ipilimumab in an ambulatory setting at Peter MacCallum cancer centre, Australia (#458)
3:00 PM
The primacy of quality of life considerations: Meeting the client’s needs. Applying flexibility in the management of secondary lymphoedema in a palliative context (#459)
3:00 PM
The impact of an inpatient hospital admission on patient’s physical functioning and quality of life rate in the oncology setting. (#460)
3:00 PM
Implementing a Leisure Activity Maintenance Program into an inpatient cancer setting (#461)
3:00 PM
Scored Patient-Generated Subjective Global Assessment and serum albumin for nutritional assessment of gynecological cancer patients in palliative care (#462)
3:00 PM
Evaluating the utility of the QUAL-EC in the clinical care of patients with advanced cancer (#463)
3:00 PM
What do patients understand about the information they receive during radiotherapy? (#464)
3:00 PM
Improving malnutrition screening in the radiotherapy setting (#465)
3:00 PM
Did the implementation of a prostate cancer specialist nursing service reduce unmet supportive care needs amongst carers? (#466)
3:00 PM
Musculoskeletal effects of exercise in men with prostate cancer initiating androgen deprivation therapy (#467)
3:00 PM
Supporting Aboriginal and Torres Strait Islander people diagnosed with cancer to navigate the healthcare system (#468)
3:00 PM
Gastrointestinal mucositis is associated with Muc 2 and 4 expression, and exocytosis of mucin stores (#469)
3:00 PM
An alternative Medical Services Advisory Committee (MSAC) assessment model: Inherited cancer as an exemplar. (#470)
3:00 PM
Factors associated with preference of communication about life expectancy with physicians among cancer patients under radiation therapy (#471)
3:00 PM
Prevalence of fatigue among cancer patients under radiation therapy and its associated factors (#472)
3:00 PM
Is crofelemer an effective intervention for dacomitinib-induced gastrointestinal toxicity? (#473)
3:00 PM
"Undressing" distress among cancer patients and carers in regional Western Australia (#474)
3:00 PM
Item generation and content validity testing of the Health Literacy of Caregivers Scale-Cancer (HeLiCaS-C) (#475)
3:00 PM